Assertive Community Treatment in Veterans Hospital Administration: Estimating Demand for Mental Health Intensive Case Management Teams in a Time of Changing Need
Methods: To address these gaps in our knowledge, we use four years of VHA program evaluation data (2007 – 2010) to define and estimate MHICM-eligible veterans using a range of eligibility algorithms. These estimates are compared to the estimates derived from current VA policy.
Findings: During our five-year study period, mental health diagnoses among Veterans increased by 25.3% and MCHIM-qualifying diagnoses increased by 28.6%. MHICM-eligibility estimates ranged from 50% to less than 1% depending on the restrictiveness of the estimating algorithm.
Implications: The number of Veterans who have behavioral health diagnoses are increasing, as are the numbers of Veterans who have MHICM-eligible diagnoses. Administrative data can be used to estimate the need for MHICM, and to inform the development of a flexible, patient-focused continuum of VA behavioral health care that aligns service intensity with intensity of need.
Learning Areas:Administration, management, leadership
Provision of health care to the public
Public health or related organizational policy, standards, or other guidelines
Public health or related research
Social and behavioral sciences
Demonstrate how national VA program evaluation data can be used to estimate the need for intensive services for Veterans with severe mental illness.
Keyword(s): Mental Health Treatment &Care, Veterans' Health
Qualified on the content I am responsible for because: I have been involved with mental health services research for over 12 years. I am a co-investigator on the project and was heavily involved in all aspects of the study.
Any relevant financial relationships? Yes
|Name of Organization||Clinical/Research Area||Type of relationship|
|Veterans Administration||Mental health services research||Consultant|
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.